Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.50 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.50 |
| ▸ | MAOA | P21397 | 1/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.50 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.50 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.50 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.50 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.50 |
| ▸ | TACR1 | P25103 | 3/20 | 0.47 |
| ▸ | IDO1 | P14902 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | AGXT | P21549 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL812240 | 1.00 | TSHR (0.52) | TSHRSLC6A2TAAR1MAOASLC6A4 | |
| SCHEMBL14193191 | 1.00 | TSHR (0.52) | TSHRSLC6A2TAAR1MAOASLC6A4 | |
| SCHEMBL14763820 | 0.84 | TSHR (0.56) | TSHRTACR1TDP1L3MBTL1CYP2C19 | |
| SCHEMBL155702 | 0.84 | TSHR (0.56) | TSHRTACR1TDP1L3MBTL1CYP2C19 | |
| SCHEMBL9452755 | 0.81 | SLC6A2 (0.53) | SLC6A2SLC6A4SLC6A3IDO1CYP2D6 | |
| SCHEMBL9452741 | 0.81 | IDO1 (0.47) | SLC6A2TAAR1MAOAIDO1 | |
| SCHEMBL20207392 | 0.81 | TSHR (0.48) | TSHRSLC6A2TAAR1MAOASLC6A4 | |
| SCHEMBL20177696 | 0.81 | TSHR (0.48) | TSHRSLC6A2TAAR1MAOASLC6A4 | |
| SCHEMBL9452770 | 0.81 | SLC6A2 (0.53) | SLC6A2SLC6A4SLC6A3IDO1CYP2D6 | |
| SCHEMBL8114898 | 0.81 | IDO1 (0.47) | SLC6A2TAAR1MAOAIDO1AGXT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9115052-B2 | Separation of an enantiomer mixture of (R)- and (S)-3-amino-1-butanol | BASF SE (DE) | 2015-08-25 | — | — | US | disclosed |
| CN-102282122-B | Separation of an enantiomer mixture of (r)- and (s)-3-amino-1-butanol | BASF SE (DE) | 2014-10-29 | — | — | CN | disclosed |
| EP-2387556-B1 | SEPARATION OF AN ENANTIOMER MIXTURE OF (R)- AND (S)-3-AMINO-1-BUTANOL | BASF SE (DE) | 2014-07-30 | — | — | EP | disclosed |
| CN-102282122-A | Separation of an enantiomer mixture of (r)- and (s)-3-amino-1-butanol | — | 2011-12-14 | — | — | CN | disclosed |
| EP-2387556-A1 | SEPARATION OF AN ENANTIOMER MIXTURE OF (R)- AND (S)-3-AMINO-1-BUTANOL | BASF SE (DE) | 2011-11-23 | — | — | EP | disclosed |
| US-20110275855-A1 | SEPARATION OF AN ENANTIOMER MIXTURE OF (R)- AND (S)-3-AMINO-1-BUTANOL | BASF SE (DE) | 2011-11-10 | — | — | US | disclosed |
| US-8040972-B2 | Wireless communication apparatus and method, and signal attenuation prediction apparatus and method | SONY CORPORATION (JP) | 2011-10-18 | — | — | US | disclosed |
| WO-2010081865-A1 | SEPARATION OF AN ENANTIOMER MIXTURE OF (R)- AND (S)-3-AMINO-1-BUTANOL | BASF SE (DE) | 2010-07-22 | — | — | WO | disclosed |
| US-7358396-B2 | Preparation of optically active amines | BASF AKTIENGESELLSCHAFT (DE) | 2008-04-15 | — | — | US | disclosed |
| US-7358396-B2 | Preparation of optically active amines | BASF AKTIENGESELLSCHAFT (DE) | 2008-04-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110275855-A1 | SEPARATION OF AN ENANTIOMER MIXTURE OF (R)- AND (S)-3-AMINO-1-BUTANOL | AP3S1, ADH5, ADH1C | TSHR 2551/4885SLC6A2 2032/4885TAAR1 147/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.